Keywords: Hyperpolarized MR (Non-Gas), Multi-Contrast, pH imaging, Sarcoma, Cat, PET/MR, Hyperpolarization, Pyruvate, Metabolism, Hypoxia
Motivation: Sarcomas are a rare but diverse cancer type with heterogeneous metabolic signatures. Their stratification is difficult, which limits treatment selection, therapy development and reliable patient prognosis.
Goal(s): To demonstrate the feasibility of combined hyperpolarized 13C MRI and PET to differentiate sarcoma subtypes and to identify prognostic imaging biomarkers.
Approach: Sarcoma cat patients were recruited, underwent PET/MR imaging and were followed-up several years post-surgery.
Results: Hyperpolarized 13C MRI of pH and pyruvate metabolism allow subtype and tumor grade differentiation while [18F]FMISO-PET and DWI do not. Image-derived tumor acidification appears to be predictive for patient outcome. Correlations between parameters reveal hypoxia-driven metabolism and related acidification.
Impact: Hyperpolarized 13C MRI allows sarcoma subtype and grade differentiation in cat patients in contrast to [18F]FMISO-PET and DWI. Acidification outperforms all other parameters as biomarker for cat patient prognosis, rendering hyperpolarized pH imaging a promising technique for clinical translation.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords